版本:
中国

BRIEF-Pacira Pharmaceuticals prices $300 mln aggregate principal amount of 2.375% convertible senior notes due 2022

March 8 Pacira Pharmaceuticals Inc:

* Pacira Pharmaceuticals announces pricing of $300 million aggregate principal amount of 2.375% convertible senior notes due 2022 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐